ReviewJournal of clinical medicine2026

Semaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms.

Luiza Barseghyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.